Gender Differences in the Association Between Subjective and Objective Cognitive Decline in a Diverse Cohort: LifeAfter90 Study
Background Few studies have investigated the relationship between subjective cognitive concerns and objective cognitive decline in the oldest‐old or examined gender differences. We evaluated this association and stratification by gender in a diverse cohort of adults ages 90+. Methods LifeAfter90 is...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2024-12, Vol.20 (S3), p.n/a |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Few studies have investigated the relationship between subjective cognitive concerns and objective cognitive decline in the oldest‐old or examined gender differences. We evaluated this association and stratification by gender in a diverse cohort of adults ages 90+.
Methods
LifeAfter90 is an ongoing cohort of adults ages 90+. Verbal episodic memory (VEM) and executive function (EF) were assessed every 6‐months since 2018 using the Spanish and English Neuropsychological Assessment Scales. We operationalized subjective cognition two ways: 1) Dichotomously as yes/no via self‐report of subjective memory concerns (SMC)‐ “are you concerned that you have a memory or other thinking problem?”; 2) Continuously as degree of self‐rated changes in cognition using the 16‐item Everyday Cognition Scale (ECog). Linear mixed models with random intercepts and slopes estimated associations of SMC or ECog with VEM and EF at baseline and longitudinally, pooled and stratified by gender (female/male). Models adjusted for baseline age, gender (in pooled models), race/ethnicity, education, interview mode (in‐person or phone), and practice effects. Sensitivity models further stratified by SMC.
Results
Participants’ (N = 499) mean baseline age 93±2.4 years, mean follow‐up time 2.7±1.1 years, 62% women, 64% racial/ethnic minorities, 41% endorsed SMC, and mean ECog score 1.45±0.5. Overall, SMC and ECog were associated with worse baseline VEM (βSMC = ‐0.44,95%CI ‐0.61,‐0.27; βECog = ‐0.40,95%CI ‐0.58,‐0.22) and worse baseline EF (βSMC = ‐0.23,95%CI ‐0.39,‐0.07; βECog = ‐0.43,95%CI ‐0.59,‐0.27) (Table 2). ECog was associated with greater decline in EF (β = ‐0.05, 95%CI ‐0.10,0.00; Table 2). There were no gender differences in associations between SMC (p = 0.44) or ECog (p = 0.33) and VEM, nor ECog and EF (p = 0.76). The association between SMC and EF differed across genders (p = 0.01). In gender‐stratified models, both genders with SMC had worse baseline VEM and worse baseline EF, though not significantly for women (βmen = ‐0.54,95%CI ‐0.79,‐0.29; βwomen = ‐0.07,95%CI ‐0.27,0.13) (Table 2). Both genders with greater ECog had worse baseline VEM (βmen = ‐0.56,95%CI ‐0.87,‐0.26; βwomen = ‐0.33,95%CI ‐0.56,‐0.10) and worse baseline EF (βmen = ‐0.43,95%CI ‐0.70,‐0.14; βwomen = ‐0.41,95%CI ‐0.61,‐0.22) (Table 2). After stratification by SMC, among those with SMC, ECog was associated with worse baseline EF (β = ‐0.47,95%CI ‐0.68,‐0.26; Table 2).
Conclusion
In this diverse cohort of 90 |
---|---|
ISSN: | 1552-5260 1552-5279 |
DOI: | 10.1002/alz.091848 |